Found 176 matching trials
FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer PHASE3 This study is designed to compare the anti-tumor activity as well as the sa...
Show More Location
The first affiliated hospital of bengbu medical college
Learn More & Join Trial
4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer PHASE1 This trial studies the best dose and side effects of utomilumab (4-1BB agon...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
Young People's Health Assessment as Treatment and Health Guide NA Background: Excessive alcohol and other substance use in adolescence is pre...
Show More Location
Primary Care Unit, University of Geneva
Learn More & Join Trial
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer PHASE3 This two-arm, randomized, open-label, multicenter study will evaluate the e...
Show More Location
HonorHealth Research Institute - Bisgrove
Learn More & Join Trial
A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function PHASE1 This open-label, parallel group study will evaluate the pharmacokinetics an...
Show More Location
Multiple Locations
Learn More & Join Trial
Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer PHASE1 The study proposes to evaluate the safety and efficacy of the combination o...
Show More Location
University of Miami
Learn More & Join Trial
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy PHASE2 This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer PHASE3 This is an open, prospective and interventional clinical study. Patients wi...
Show More Location
The First Affiliated Hospital of Xi'an Jiaotong University
Learn More & Join Trial
A Study of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer PHASE2 Study of trastuzumab emtansine (T-DM1) administered to patients with human ...
Show More Location
Multiple Locations
Learn More & Join Trial
Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer PHASE2 This is a multicenter, open-label, single-arm, one-stage, phase II study to...
Show More Status
Active Not Recruiting
Location
UMHAT Sveti Ivan Rilski EAD Department of Medical Oncology
Learn More & Join Trial